Perspectives on Dual Targeting Delivery Systems for Brain Tumors

J Neuroimmune Pharmacol. 2017 Mar;12(1):6-16. doi: 10.1007/s11481-016-9687-4. Epub 2016 Jun 8.

Abstract

Brain tumor remains one of the most serious threats to human beings. Different from peripheral tumors, drug delivery to brain tumor is largely restricted by the blood brain barrier (BBB). To fully conquer this barrier and specifically deliver drugs to brain tumor, dual targeting delivery systems were explored, which are functionalized with two active targeting ligands: one to the BBB and the other to the brain tumor. The development of dual targeting delivery system is still in its early stage, and attentions need to be paid to issues and concerns that remain unresolved in future studies.

Keywords: Blood brain barrier; Brain tumor; Drug delivery systems; Dual targeting.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Biological Transport / drug effects
  • Biological Transport / physiology
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / metabolism
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism
  • Drug Delivery Systems / methods*
  • Drug Delivery Systems / trends
  • Humans
  • Nanoparticles / administration & dosage*
  • Nanoparticles / metabolism

Substances

  • Antineoplastic Agents